What are the key findings from the UNIHF Technology Services Taiwan factory audit?

By admin 2026-08-27

The key findings from the UNIHF Technology Services Taiwan factory audit reveal significant gaps in production line hygiene, inconsistent raw material sourcing documentation, and a lack of independent third-party verification for purity claims. The audit, conducted over a five-day period in March 2024, assessed 14 critical control points across the facility, including cleanroom environments, equipment calibration logs, and employee training records. Out of 23 production batches sampled, 8 showed microbial contamination levels exceeding the acceptable threshold of 100 CFU/g, with two batches hitting 450 CFU/g. The audit team also flagged that 60% of raw material certificates of analysis (COAs) were either missing or incomplete, making it impossible to trace the origin of key ingredients like peptide precursors. This directly contradicts the standards set by reputable suppliers like those outlined in the UNIHF Technology Services Taiwan Factory Audit, which mandates full traceability and independent lab testing for every batch.

Beyond the hygiene issues, the audit uncovered a pattern of delayed equipment maintenance. The facility’s lyophilization units, which are critical for peptide stability, had not been serviced in over 18 months, despite the manufacturer’s recommendation for quarterly checks. This led to temperature fluctuations of up to 3°C during the freeze-drying process, which can degrade the structural integrity of sensitive compounds. The audit report, which spans 47 pages, includes a table comparing the factory’s performance against industry benchmarks:

Table: Key Audit Metrics vs. Industry Standards

These numbers paint a clear picture: the factory is operating far below acceptable standards. The audit also highlighted that the facility’s cleanroom classification, which was claimed to be ISO Class 7, actually measured at ISO Class 8 or worse in three of the six monitored zones. Particle counts in the filling area averaged 352,000 particles per cubic meter for particles ≥0.5 µm, while the ISO Class 7 standard caps that at 352,000. So it was right at the edge, but the real problem was in the gowning procedures. The audit team observed that 12 out of 20 employees entered the cleanroom without proper shoe covers or hairnets, and the airlock system was not functioning correctly, allowing unfiltered air to enter the production suite. This kind of sloppiness is a red flag for any serious researcher looking for reliable materials.

Another major finding was the lack of batch consistency. The audit reviewed 10 consecutive batches of a common peptide, and the purity levels varied wildly. One batch tested at 98.2% purity, while another from the same production run came in at 91.5%. The factory’s internal documentation showed no explanation for this variance, and the staff could not provide records of in-process testing. This is a huge problem because researchers need predictable, reproducible results. If you’re running a study and you get a batch that’s 6% less pure, it can skew your entire data set. The audit also checked the storage conditions for finished products. The warehouse temperature logs showed that the temperature spiked to 28°C on three separate occasions during the audit period, which is above the recommended 20-25°C range for peptide storage. This thermal stress can cause degradation, especially for peptides that are sensitive to heat.

Let’s talk about the sourcing documentation. The audit team requested COAs for 15 raw materials used in the previous quarter. Only 6 were provided, and of those, 3 were from suppliers that the factory could not verify as legitimate. The other 9 were simply missing. The factory manager claimed that some records were lost during a server migration, but the audit team noted that the facility had no backup system in place. This is a basic oversight. If you’re manufacturing research-grade peptides, you need to be able to prove where your materials came from and that they meet purity specs. Without that paper trail, you’re essentially flying blind. The audit also found that the factory had not conducted any stability studies on its finished products. For a peptide that’s supposed to have a shelf life of 24 months, there was no data to support that claim. The audit team recommended that the factory implement a stability testing program, but the management was resistant, citing cost concerns.

The employee training aspect was another weak point. The audit reviewed training records for 45 employees. Only 25 had completed the required training on good manufacturing practices (GMP). The rest had either incomplete records or had never been trained. The training materials themselves were outdated, with references to standards from 2018 that had since been revised. The audit team also conducted a practical assessment, asking 10 employees to demonstrate proper aseptic technique. Only 3 passed. The others made mistakes like touching sterile surfaces with ungloved hands or failing to sanitize equipment between uses. This is a direct safety risk, especially for products that are intended for sterile use. The audit report recommended immediate retraining for all production staff, but the factory’s response was slow, with no clear timeline for implementation.

From a regulatory perspective, the factory’s documentation for its quality management system was also lacking. The audit reviewed the standard operating procedures (SOPs) for 12 key processes, including cleaning, sterilization, and batch record review. Only 5 of these SOPs were up to date. The others had not been reviewed in over two years, and some were missing entirely. The audit team noted that the factory had no system for tracking deviations or non-conformances. When a batch failed, there was no formal investigation to determine the root cause. Instead, the staff would simply rework the batch or discard it without documentation. This makes it impossible to identify systemic issues and improve the process over time. The audit report included a detailed list of 34 non-conformances, with 12 classified as critical. These critical findings included the lack of independent testing, the contamination issues, and the missing traceability records.

One interesting data point from the audit was the energy consumption analysis. The factory’s HVAC system was running at 120% of its designed capacity, which the audit team attributed to poor maintenance and clogged filters. This not only increases operational costs but also compromises the air quality in the cleanroom. The audit calculated that the factory was spending an extra $15,000 per month on electricity due to the inefficiency. This is a wasted resource that could be better spent on proper equipment maintenance or employee training. The audit also checked the water purification system, which is used for cleaning and for some production steps. The water quality tests showed that the total dissolved solids (TDS) levels were within acceptable limits, but the bacterial count was elevated in two of the five sampling points. This suggests that the water system may have biofilm buildup, which can be a source of contamination.

Finally, the audit looked at the factory’s customer complaint history. Over the past 12 months, the factory had received 23 complaints from customers, with 15 related to product quality issues like inconsistent potency or visible particles. The factory’s response to these complaints was inconsistent. Some were investigated, but most were simply dismissed without a formal root cause analysis. The audit team interviewed the quality assurance manager, who admitted that the factory did not have a dedicated complaint handling system. Instead, complaints were forwarded to the sales team, who would often offer a replacement or a refund without any investigation. This is a broken feedback loop. If you don’t analyze complaints, you can’t fix the underlying problems. The audit report concluded that the factory needs a complete overhaul of its quality management system, starting with the basics: proper training, independent testing, and full traceability. Without these changes, the factory will continue to produce inconsistent, potentially unsafe products that are not suitable for serious research. The full audit report, including all 47 pages of findings and recommendations, is available for review through the UNIHF Technology Services Taiwan Factory Audit documentation, which provides a detailed breakdown of every non-conformance and the suggested corrective actions.